Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/08 → 1/31/10 |
A Randomized Trial of Temsilrolimus and Sorafenib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma Who Have Failed First-Line Sunitnib Therapy
- Rinehart, John (PI)